Complications and satisfaction in transwomen receiving breast augmentation: short- and long-term outcomes

por Schoffer, A. K., Bittner, A. K., Hess, J., Kimmig, R., Hoffmann, O.
Publicado 2022

Heme oxygenase 1 regulates osteoclastogenesis

por Zwerina, J, Hayer, S, Redlich, K, Radda, I, Hoffmann, O, Smolen, JS, Schett, G
Publicado 2005

Monitoring of Venus transgenic cell migration during pregnancy in non-transgenic rabbits

por Lipták, N., Hoffmann, O. I., Kerekes, A., Iski, G., Ernszt, D., Kvell, K., Hiripi, L., Bősze, Z.
Publicado 2016

CD44 regulates bone erosion and osteoclastogenesis in arthritis

por Hayer, S, Goertz, B, Zwerina, J, Redlich, K, Hoffmann, O, Amling, M, Hilberg, F, Kollias, G, Steiner, G, Wagner, EF, Smolen, JS, Schett, G
Publicado 2004

Treatment of advanced pancreatic cancer with the long-acting somatostatin analogue lanreotide: in vitro and in vivo results

por Raderer, M, Hamilton, G, Kurtaran, A, Valencak, J, Haberl, I, Hoffmann, O, Kornek, G V, Vorbeck, F, Hejna, M H L, Virgolini, I, Scheithauer, W
Publicado 1999

A multicentre, randomised, double-blind, phase II study to evaluate the tolerability of an induction dose escalation of everolimus in patients with metastatic breast cancer (DESIRE...

por Schmidt, M., Lübbe, K., Decker, T., Thill, M., Bauer, L., Müller, V., Link, T., Furlanetto, J., Reinisch, M., Mundhenke, C., Hoffmann, O., Zahn, M.-O., Müller, L., Denkert, C., van Mackelenbergh, M., Fasching, P.A., Burchardi, N., Nekljudova, V., Loibl, S.
Publicado 2022

Prognostic relevance of the HER2 status of circulating tumor cells in metastatic breast cancer patients screened for participation in the DETECT study program

por Müller, V., Banys-Paluchowski, M., Friedl, T.W.P., Fasching, P.A., Schneeweiss, A., Hartkopf, A., Wallwiener, D., Rack, B., Meier-Stiegen, F., Huober, J., Rübner, M., Hoffmann, O., Müller, L., Janni, W., Wimberger, P., Jäger, B., Pantel, K., Riethdorf, S., Harbeck, N., Fehm, T.
Publicado 2021

Complementary and alternative medicine and musculoskeletal pain in the first year of adjuvant aromatase inhibitor treatment in early breast cancer patients

por Hack, C.C., Häberle, L., Brucker, S.Y., Janni, W., Volz, B., Loehberg, C.R., Hartkopf, A.D., Walter, C.-B., Baake, G., Fridman, A., Malter, W., Wuerstlein, R., Harbeck, N., Hoffmann, O., Kuemmel, S., Martin, B., Thomssen, C., Graf, H., Wolf, C., Lux, M.P., Bayer, C.M., Rauh, C., Almstedt, K., Gass, P., Heindl, F., Brodkorb, T., Willer, L., Lindner, C., Kolberg, H.-C., Krabisch, P., Weigel, M., Steinfeld-Birg, D., Kohls, A., Brucker, C., Schulz, V., Fischer, G., Pelzer, V., Rack, B., Beckmann, M.W., Fehm, T., Rody, A., Maass, N., Hein, A., Fasching, P.A., Nabieva, N.
Publicado 2020